title: Intravenous cyclophosphamide in refractory polyneuropathy associated with IgM monoclonal gammopathy: an uncontrolled open trial.
authors.affiliation: Department of Internal Medicine, University Hospital, Hôtel-Dieu, Place Alexis Ricordeau, Nantes 44-035, France. mohamed.hamidou@chu-nantes.fr
authors.forename: Mohamed A
authors.initials: MA
authors.lastname: Hamidou
authors.forename: Cristina
authors.initials: C
authors.lastname: Belizna
authors.forename: Sandrine
authors.initials: S
authors.lastname: Wiertlewsky
authors.forename: Marie
authors.initials: M
authors.lastname: Audrain
authors.forename: Charlotte
authors.initials: C
authors.lastname: Biron
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Grolleau
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Mussini
mesh_terms: D003520:Cyclophosphamide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007075:Immunoglobulin M / Q000276:immunology*; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010265:Paraproteinemias / Q000150:complications*; D011115:Polyneuropathies / Q000188:drug therapy*; D011446:Prospective Studies; D020551:Pulse Therapy, Drug; D016896:Treatment Outcome
chemical_list: D007075:Immunoglobulin M; D003520:Cyclophosphamide